Combination immunotherapy of glioblastoma with dendritic cell cancer vaccines, anti-PD-1 and poly I:C
/in Dendritic Cells, Glioblastoma, International PublicationsDendritic cell vaccines in breast cancer: Immune modulation and immunotherapy
/in Breast Cancer, Dendritic Cells, International PublicationsThe Current Status, Challenges, and Future Potential of Therapeutic Vaccination in Glioblastoma
/in Dendritic Cells, Glioblastoma, International PublicationsPersonalized dendritic cell vaccination in cancer therapy: An evidence-based research study
/in Dendritic Cells, International PublicationsA randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma
/in Dendritic Cells, International Publications, Malignant MelanomaAutologous dendritic cell vaccination against HIV-1 induces changes in natural killer cell phenotype and functionality
/in Dendritic Cells, Glioblastoma, International PublicationsAnti-TNFR2 enhanced the antitumor activity of a new HMGN1/3M-052 stimulated dendritic cell vaccine in a mouse model of colon cancer
/in Colorectal Cancer, Dendritic Cells, International PublicationsIndividualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience
/in Dendritic Cells, Glioblastoma, International Publications, IOZK VeröffentlichungenGlioblastoma treatment slowly moves towards change: novel druggable targets and translational horizons in 2022
/in Dendritic Cells, Glioblastoma, International Publications, Newcastle Disease Virus
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer